The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt et al. · BMJ · 2021 · 95K citations · Full text

Public Health, Internal Medicine, Meta-analysis +10

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

Salim S. Virani, Álvaro Alonso, Emelia J. Benjamin et al. · Circulation · 2020 · 9.4K citations · Full text

Medicine, Cardiology, Chronic Disease Prevention +17

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Charles E. Murry, Robert B. Jennings, K A Reimer · Circulation · 1986 · 7.8K citations · Full text

Medicine, Cardiology, Physiology +13

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

Salim Yusuf, Philip Joseph, Sumathy Rangarajan et al. · The Lancet · 2019 · 2K citations · Full text

Public Health, Chronic Disease Prevention, Preventive Medicine +17

Myocardial reperfusion: a double-edged sword?

Eugene Braunwald, Robert A. Kloner · Journal of Clinical Investigation · 1985 · 1.4K citations · Full text

Medicine, Cardiology, Surgery +14